Pregnancy/Implantation Rates Using a Day 3 Score Versus Graduated Embryo Score Plus a Biochemical Marker (sHLA-G)
Completed
University of Stellenbosch
N/A
2004-06-01
Objective: To compare pregnancy rates and implantation rates when embryos are selected based
on a single Day 3 (D.3) score vs. a GES score plus sHLA-G expression.
Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization Cycle
Completed
Ferring Pharmaceuticals
Phase 3
2009-09-01
This goal of this study is to evaluate the outcomes from in vitro fertilization cycles where
a 450 IU daily dose of gonadotropins is administered compared to those where a 600 IU daily
dose is administered for women who are at risk of a poor ovarian response in order to
determine if one dose or the other results in improved cycle outcomes.
Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization Cycle
Completed
Clinique Ovo
Phase 3
2009-09-01
This goal of this study is to evaluate the outcomes from in vitro fertilization cycles where
a 450 IU daily dose of gonadotropins is administered compared to those where a 600 IU daily
dose is administered for women who are at risk of a poor ovarian response in order to
determine if one dose or the other results in improved cycle outcomes.
Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization Cycle
Completed
OVO R & D
Phase 3
2009-09-01
This goal of this study is to evaluate the outcomes from in vitro fertilization cycles where
a 450 IU daily dose of gonadotropins is administered compared to those where a 600 IU daily
dose is administered for women who are at risk of a poor ovarian response in order to
determine if one dose or the other results in improved cycle outcomes.
The aim of the current study was the pharmacokinetic and pharmacodynamic characterization of
a single dose administration of four doses of FSH-GEX™ in healthy pituitary-suppressed female
volunteers, in comparison with two marketed comparator products.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
